BOSTON, MA — Stark / Raving Health, a clinical trial marketing agency specializing in accelerating global patient recruitment, today announced the release of a groundbreaking white paper, “Modern Strategies for Patient Recruitment in Oncology Trials,” addressing one of the most critical challenges in cancer research: connecting eligible patients with potentially life-saving clinical trials.
The white paper comes at a crucial time, as approximately 80% of oncology trials fail to meet their enrollment timelines, with less than 5% of cancer patients participating in clinical trials. This comprehensive framework provides practical solutions for transforming patient recruitment in an era of increasingly precise inclusion criteria and personalized medicine.
“Every day of delay in trial recruitment represents missed opportunities for cancer patients seeking potential options,” said Matthew Stumm, President and Founder of Stark / Raving Health. “As leaders in patient recruitment, we have both the capability and the responsibility to transform how we connect patients with clinical trials. This framework represents our commitment to accelerating cancer research through smarter, more efficient recruitment strategies.”
Key insights from the white paper include:
- A novel “Hunter-Gatherer” media model that revolutionizes how organizations can reach potential trial participants
- Detailed strategies for engaging referring oncologists through digital channels
- Patient-centric approaches that address both practical and emotional barriers to trial participation
- Comprehensive frameworks for trial awareness and education
- Implementation strategies for optimizing recruitment processes
The white paper presents actionable solutions for all stakeholders in the clinical trial ecosystem, from pharmaceutical companies and research institutions to healthcare providers and patient advocacy groups. For pharmaceutical companies and research institutions, recruitment delays currently account for an estimated 40% of trial budget overruns, while patients awaiting new treatment options face profound personal consequences.
The complete white paper is available for download here.
About Stark / Raving Health
Stark / Raving Health combines clinical trial expertise, award-winning creativity, and sophisticated media strategies to accelerate global patient recruitment. Operating in over 50 countries and 70 languages, we drive enrollment success through our unique blend of therapeutic insight and digital innovation. This powerful approach has established us as the trusted partner for leading biotechs, pharmaceutical companies, and CROs transforming clinical trials through strategic, patient-inspired campaigns.
To learn more, visit www.starkravinghealth.com